抑郁试验结局指标异质性与患者关注内容的相关性:一项系统综述
该系统综述分析了2018至2022年间注册的450项成人单相和双相抑郁随机对照试验,共识别出388种不同的结局测量工具。其中40%的试验使用同一工具(汉密尔顿抑郁量表HAMD),且HAMD最多仅覆盖80个患者关注领域中的47个(59%),有7个(9%)领域未被最常用的25种工具覆盖。
要点
- 450项抑郁随机对照试验中使用了388种不同结局测量工具,异质性高。
- 40%的试验使用HAMD,但HAMD最多覆盖80个患者关注领域中的47个(59%)。
- 7个(9%)患者关注领域未被最常用的25种测量工具覆盖,如精神痛苦和易激惹。
核心结论
- 抑郁随机对照试验结局测量工具高度异质,且常用工具未充分覆盖患者关注的领域,造成研究浪费。
- 在核心结局指标集建立前,可选用最常用工具并搭配互补量表以优化领域覆盖。
研究设计与样本
- 系统综述,纳入2018至2022年间注册的450项成人单相和双相抑郁随机对照试验。
- 由患者和临床医生将25种最常用测量工具的条目与80个先前确定的患者关注抑郁领域进行匹配。
主要发现
- 共识别出388种不同的结局测量工具。
- 40%的随机对照试验使用同一测量工具HAMD。
- 7个(9%)患者关注领域未被25种最常用测量工具覆盖,例如精神痛苦和易激惹。
- HAMD最多覆盖80个患者关注领域中的47个(59%)。
关键数值与推荐
- 25种最常用测量工具中,7个(9%)患者关注领域未被覆盖。
- HAMD对80个患者关注领域的最大覆盖数为47个(59%)。
临床怎么用
- 在核心结局指标集建立前,可选用最常用测量工具并选择互补量表以优化对患者关注领域的覆盖。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Research waste occurs when randomised controlled trial (RCT) outcomes are heterogeneous or overlook domains that matter to patients (eg, relating to symptoms or functions). In this systematic review, we reviewed the outcome measures used in 450 RCTs of adult unipolar and bipolar depression registered between 2018 and 2022 and identified 388 different measures. 40% of the RCTs used the same measure (Hamilton Depression Rating Scale [HAMD]). Patients and clinicians matched each item within the 25 most frequently used measures with 80 previously identified domains of depression that matter to patients. Seven (9%) domains were not covered by the 25 most frequently used outcome measures (eg, mental pain and irritability). The HAMD covered a maximum of 47 (59%) of the 80 domains that matter to patients. An interim solution to facilitate evidence synthesis before a core outcome set is developed would be to use the most common measures and choose complementary scales to optimise domain coverage. TRANSLATIONS: For the French and Dutch translations of the abstract see Supplementary Materials section.
引用
- Veal C, Tomlinson A, Cipriani A, et al. Heterogeneity of outcome measures in depression trials and the relevance of the content of outcome measures to patients: a systematic review. Lancet Psychiatry. 2024. PMID: 38490761. doi:10.1016/S2215-0366(23)00438-8
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。